Maintenance Olaparib in Patients with Newly Diagnosed Advanced Ovarian Cancer
2018 · New England Journal of Medicine · 2,701 citations
https://doi.org/10.1056/nejmoa1810858
N
Nicoletta Colombo
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
802
Papers
54.2K
Citations
102
h-index
374
i10-index
Nicoletta Colombo is an academic researcher from University of Milan. The author has contributed to research in topics: Ovarian cancer diagnosis and treatment & PARP inhibition in cancer therapy & Endometrial and Cervical Cancer Treatments. The author has an h-index of 102, co-authored 682 publications.
ORCID: 0000-0003-2225-715XPapers by this author
worksPaclitaxel plus platinum-based chemotherapy versus conventional platinum-based chemotherapy in women with relapsed ovarian cancer: the ICON4/AGO-OVAR-2.2 trial
2003 · The Lancet · 1,193 citations
https://doi.org/10.1016/s0140-6736(03)13718-x
ESMO–ESGO consensus conference recommendations on ovarian cancer: pathology and molecular biology, early and advanced stages, borderline tumours and recurrent disease
2019 · Annals of Oncology · 1,101 citations
https://doi.org/10.1093/annonc/mdz062
ESMO–ESGO consensus conference recommendations on ovarian cancer: pathology and molecular biology, early and advanced stages, borderline tumours and recurrent disease
2019 · Annals of Oncology · 1,101 citations
https://doi.org/10.1093/annonc/mdz062
ESMO-ESGO-ESTRO Consensus Conference on Endometrial Cancer
2015 · International Journal of Gynecological Cancer · 745 citations
https://doi.org/10.1097/igc.0000000000000609
Mirvetuximab Soravtansine in FRα-Positive, Platinum-Resistant Ovarian Cancer
2023 · New England Journal of Medicine · 336 citations
https://doi.org/10.1056/nejmoa2309169
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat